Skip to main content

Table 3 Final adjusted logistic regression model

From: Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil

  b OR CI 95% p value
Present vs. Absent
 Age, years 0.028 1.03 1.02 1.04 < 0.001
 Duration of DM, years 0.067 1.07 1.05 1.09 < 0.001
 HbA1c (%) 0.216 1.24 1.17 1.32 < 0.001
 Serum uric acid, mg/dL 0.196 1.22 1.13 1.31 < 0.001
 Use of an angiotensin-converting enzyme (ACE) inhibitor, yes 0.563 1.78 1.26 2.43 < 0.001
 Macrovascular disease, yes 0.813 2.26 1.08 4.71 0.03
 Arterial hypertension, yes 0.521 1.68 1.13 2.5 0.01
VTDR vs. Non-VTDR
 Duration of DM, years 0.075 1.08 1.06 1.1 < 0.001
 HbA1c % 0.105 1.11 1.02 1.21 0.014
 Serum uric acid, mg/dL 0.219 1.25 1.13 1.37 < 0.001
 Use of an angiotensin-converting enzyme (ACE) inhibitor yes 0.774 2.17 1.51 3.11 < 0.001
 LDL cholesterol, mg/dL −0.01 0.99 0.99 1 0.019
 Chronic kidney disease, yes 0.925 2.52 1.69 3.77 < 0.001
  1. VTDR vision-threatening diabetic retinopathy, HbA1c glycated hemoglobin, LDL-c low density lipoprotein cholesterol, b coefficient for logistic regression; OR odds ratio, CI 95% 95% confidence interval